The invention relates to a composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5’ -monophosphate-activated Protein kinase (AMPK) activator a second agent that possesses anti-inflammatory activity and a third agent that possesses serotonin activity.本發明係關於一種組成物,其包括一第一藥劑,其選自於由下列所組成之群:氧化磷酸化抑制劑、離子載體及經腺苷酸5’-單磷酸鹽活化的蛋白質激酶(AMPK)激活劑;一第二藥劑,其擁有抗炎性活性;及一第三藥劑,其擁有血清素活性。
